<p>ASP 同位素公司（NASDAQ：ASPI - 获取免费报告）成为七月份空头头寸显著增长的目标。截至 7 月 31 日，空头头寸总计达到 6,730,000 股，比 7 月 15 日的 5,470,000 股增长了 23.0%。目前，该公司的股份中有 19.1% 被空头持有。根据平均每日交易量为 1,120,000 股，目前的空头头寸比率为 6.0 天。</p>
<h2>ASP 同位素交易上涨 1.9%</h2>
<p>NASDAQ：ASPI 的股价于周四开盘为$2.15。ASP 同位素过去 12 个月的最低价为$0.84，最高价为$5.67。该股的市值为 1.1129 亿美元，市盈率为-4.06，贝塔系数为 5.16。公司的 50 日移动平均价为$3.12，200 日移动平均价为$3.53。该公司的速动比率为 3.57，流动比率为 3.57，负债权益比为 1.70。</p>
<p>ASP 同位素（NASDAQ：ASPI - 获取免费报告）上次公布季度财报是在 5 月 15 日周三。该公司报告该季度每股亏损 ($0.16)。该季度公司营收为 840 万美元。作为一组，股票研究分析师预测 ASP 同位素今年将实现每股-0.11 美元的盈利。</p>
<h2>华尔街分析师预测增长</h2>
<p>另外，HC Wainwright 将 ASP 同位素的目标股价从$5.50 降至$4.50，并在 8 月 7 日周三的报告中为该公司设定了 “买入” 评级。</p>
<p><strong>查看我们关于 ASPI 的最新股票报告</strong></p>
<h2>内部人员的买卖行为</h2>
<p>在其他 ASP 同位素的消息中，主要股东 Ak Jensen Investment Managemen 于 7 月 10 日周三购买了 61,849 股 ASP 同位素股票。该股票的平均价格为每股$3.40，总交易额为$210,286.60。完成收购后，该内部人员现在拥有公司股票的 6,678,723 股，价值约$22,707,658.20。该购买行为已在证券交易委员会的一份文件中披露，可在此链接中查看。目前有 26.30% 的股份由公司内部人员持有。</p>
<h2>机构投资者对 ASP 同位素的看法</h2>
<p>一些机构投资者最近对该公司的持股进行了调整。HTLF 银行在第四季度收购了 ASP 同位素的新股份，价值约 141,000 美元。Rathbones Group PLC 在第四季度收购了 ASP 同位素的新股份，价值约 272,000 美元。Vanguard Group Inc.在第一季度将其在 ASP 同位素的持股增加了 479.1%。Vanguard Group Inc.现在拥有该公司的 1,021,019 股股份，价值 4,217,000 美元，比上一季度增加了 844,705 股。Virtu Financial LLC 在第一季度将其在 ASP 同位素的持股增加了 477.0%。Virtu Financial LLC 现在拥有该公司的 83,677 股股份，价值 346,000 美元，比上一季度增加了 69,176 股。最后，纽约梅隆银行在第二季度收购了 ASP 同位素的新股份，价值约 381,000 美元。机构投资者拥有该公司 16.80% 的股份。</p>
<h2>ASP 同位素公司简介（获取免费报告）</h2>
<p>ASP 同位素公司是一家发展阶段的先进材料公司，专注于同位素的生产、分销、营销和销售。它从事钼-100、碳-14 和硅-28 的生产和商业化。该公司还正在开发量子富集技术，用于生产钇-176、镍-64、锂 6、锂 7 和铀-235。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们喜欢的五支股票胜过 ASP 同位素</li>
<li>现在购买宝洁股票，趁着它创下新的历史高点之前</li>
<li>开启增长：为什么 Arcos Dorados 应该出现在您的投资组合中</li>
<li>为什么这些公司被视为蓝筹股？</li>
<li>忘记无人驾驶出租车：电动飞行出租车是下一个重要投资</li>
<li>最活跃的股票：交易额与股票量</li>
<li>Crocs 股价在盈利超预期后下滑：它会反弹吗？</li>
</ul>
<p><em>此即时新闻警报由叙事科学技术和 MarketBeat 的财务数据生成，以向读者提供最快速和最准确的报道。本故事在发布前已经经 MarketBeat 的编辑团队审核。请将有关本故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<p>→ 衰退证明的股票？（来自 Stansberry Research）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MTY5?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MTY5"/></p>
<h2>现在是否值得投资$1,000 购买 ASP 同位素？</h2>
<p>在考虑 ASP 同位素之前，您可能想听听这个。</p>
<p>MarketBeat 追踪华尔街顶级和表现最佳的研究分析师以及他们每天向客户推荐的股票。MarketBeat 已确定了五支顶级分析师悄悄告诉客户现在购买的股票，然后才会被更广泛的市场注意到...而 ASP 同位素并不在这份名单上。</p>
<p>尽管 ASP 同位素目前在分析师中有 “买入” 评级，但顶级分析师认为这五支股票更值得购买。</p>
<p>查看这五支股票</p>

ASPI

<p>ASP 同位素公司（NASDAQ：ASPI）在 7 月份经历了短期空头头寸的显著增长，增幅达到了 23.0%，达到了 6,730,000 股。大约 19.1% 的股票被做空，根据平均交易量为 1,120,000 股，以 6.0 的天数来计算。机构投资者增加了他们的持仓，其中先锋集团（Vanguard）将其持股增加了 479.1%。该公司从事为医疗行业生产同位素的业务，包括钼-100 和碳-14</p>

<p>ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) was the target of a significant growth in short interest in the month of July. As of July 31st, there was short interest totalling 6,730,000 shares, a growth of 23.0% from the July 15th total of 5,470,000 shares. Currently, 19.1% of the shares of the company are sold short. Based on an average daily volume of 1,120,000 shares, the short-interest ratio is currently 6.0 days.</p>
<div class="lb-trans"><p>ASP 同位素公司（NASDAQ：ASPI - 获取免费报告）成为七月份空头头寸显著增长的目标。截至 7 月 31 日，空头头寸总计达到 6,730,000 股，比 7 月 15 日的 5,470,000 股增长了 23.0%。目前，该公司的股份中有 19.1% 被空头持有。根据平均每日交易量为 1,120,000 股，目前的空头头寸比率为 6.0 天。</p>
</div><h2>ASP Isotopes Trading Up 1.9 %</h2>
<div class="lb-trans"><h2>ASP 同位素交易上涨 1.9%</h2>
</div><p>Shares of NASDAQ:ASPI opened at $2.15 on Thursday. ASP Isotopes has a 12-month low of $0.84 and a 12-month high of $5.67. The stock has a market cap of $111.29 million, a PE ratio of -4.06 and a beta of 5.16. The business has a 50 day moving average of $3.12 and a 200-day moving average of $3.53. The company has a quick ratio of 3.57, a current ratio of 3.57 and a debt-to-equity ratio of 1.70.</p>
<div class="lb-trans"><p>NASDAQ：ASPI 的股价于周四开盘为$2.15。ASP 同位素过去 12 个月的最低价为$0.84，最高价为$5.67。该股的市值为 1.1129 亿美元，市盈率为-4.06，贝塔系数为 5.16。公司的 50 日移动平均价为$3.12，200 日移动平均价为$3.53。该公司的速动比率为 3.57，流动比率为 3.57，负债权益比为 1.70。</p>
</div><p>ASP Isotopes (NASDAQ:ASPI - Get Free Report) last issued its quarterly earnings data on Wednesday, May 15th. The company reported ($0.16) earnings per share (EPS) for the quarter. The firm had revenue of $0.84 million during the quarter. As a group, equities research analysts forecast that ASP Isotopes will post -0.11 earnings per share for the current year.</p>
<div class="lb-trans"><p>ASP 同位素（NASDAQ：ASPI - 获取免费报告）上次公布季度财报是在 5 月 15 日周三。该公司报告该季度每股亏损 ($0.16)。该季度公司营收为 840 万美元。作为一组，股票研究分析师预测 ASP 同位素今年将实现每股-0.11 美元的盈利。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>Separately, HC Wainwright reduced their price target on ASP Isotopes from $5.50 to $4.50 and set a &#34;buy&#34; rating for the company in a report on Wednesday, August 7th.</p>
<div class="lb-trans"><p>另外，HC Wainwright 将 ASP 同位素的目标股价从$5.50 降至$4.50，并在 8 月 7 日周三的报告中为该公司设定了 “买入” 评级。</p>
</div><p><strong>View Our Latest Stock Report on ASPI</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 ASPI 的最新股票报告</strong></p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部人员的买卖行为</h2>
</div><p>In other ASP Isotopes news, major shareholder Ak Jensen Investment Managemen purchased 61,849 shares of ASP Isotopes stock in a transaction that occurred on Wednesday, July 10th. The stock was acquired at an average price of $3.40 per share, for a total transaction of $210,286.60. Following the completion of the acquisition, the insider now owns 6,678,723 shares of the company's stock, valued at approximately $22,707,658.20. The purchase was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at this link. 26.30% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他 ASP 同位素的消息中，主要股东 Ak Jensen Investment Managemen 于 7 月 10 日周三购买了 61,849 股 ASP 同位素股票。该股票的平均价格为每股$3.40，总交易额为$210,286.60。完成收购后，该内部人员现在拥有公司股票的 6,678,723 股，价值约$22,707,658.20。该购买行为已在证券交易委员会的一份文件中披露，可在此链接中查看。目前有 26.30% 的股份由公司内部人员持有。</p>
</div><h2>Institutional Investors Weigh In On ASP Isotopes</h2>
<div class="lb-trans"><h2>机构投资者对 ASP 同位素的看法</h2>
</div><p>A number of institutional investors have recently made changes to their positions in the company. HTLF Bank acquired a new stake in shares of ASP Isotopes in the fourth quarter valued at approximately $141,000. Rathbones Group PLC acquired a new stake in shares of ASP Isotopes in the fourth quarter valued at approximately $272,000. Vanguard Group Inc. raised its position in shares of ASP Isotopes by 479.1% in the first quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company's stock valued at $4,217,000 after buying an additional 844,705 shares in the last quarter. Virtu Financial LLC raised its position in shares of ASP Isotopes by 477.0% in the first quarter. Virtu Financial LLC now owns 83,677 shares of the company's stock valued at $346,000 after buying an additional 69,176 shares in the last quarter. Finally, Bank of New York Mellon Corp acquired a new stake in shares of ASP Isotopes in the second quarter valued at approximately $381,000. Institutional investors own 16.80% of the company's stock.</p>
<div class="lb-trans"><p>一些机构投资者最近对该公司的持股进行了调整。HTLF 银行在第四季度收购了 ASP 同位素的新股份，价值约 141,000 美元。Rathbones Group PLC 在第四季度收购了 ASP 同位素的新股份，价值约 272,000 美元。Vanguard Group Inc.在第一季度将其在 ASP 同位素的持股增加了 479.1%。Vanguard Group Inc.现在拥有该公司的 1,021,019 股股份，价值 4,217,000 美元，比上一季度增加了 844,705 股。Virtu Financial LLC 在第一季度将其在 ASP 同位素的持股增加了 477.0%。Virtu Financial LLC 现在拥有该公司的 83,677 股股份，价值 346,000 美元，比上一季度增加了 69,176 股。最后，纽约梅隆银行在第二季度收购了 ASP 同位素的新股份，价值约 381,000 美元。机构投资者拥有该公司 16.80% 的股份。</p>
</div><h2>ASP Isotopes Company Profile (Get Free Report)</h2>
<div class="lb-trans"><h2>ASP 同位素公司简介（获取免费报告）</h2>
</div><p>ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.</p>
<div class="lb-trans"><p>ASP 同位素公司是一家发展阶段的先进材料公司，专注于同位素的生产、分销、营销和销售。它从事钼-100、碳-14 和硅-28 的生产和商业化。该公司还正在开发量子富集技术，用于生产钇-176、镍-64、锂 6、锂 7 和铀-235。</p>
</div><h2>Further Reading</h2>
<ul>
<li>Five stocks we like better than ASP Isotopes</li>
<li>Buy P&amp;G Now, Before It Sets A New All-Time High</li>
<li>Unlocking Growth: Why Arcos Dorados Belongs in Your Portfolio</li>
<li>Why Are These Companies Considered Blue Chips?</li>
<li>Forget Robotaxis: Electric Air Taxis are the Next Big Investment</li>
<li>Most active stocks: Dollar volume vs share volume</li>
<li>Crocs Stock Slips After Earnings Beat: Will It Bounce Back?</li>
</ul>
<div class="lb-trans"><h2>进一步阅读</h2>
<ul>
<li>我们喜欢的五支股票胜过 ASP 同位素</li>
<li>现在购买宝洁股票，趁着它创下新的历史高点之前</li>
<li>开启增长：为什么 Arcos Dorados 应该出现在您的投资组合中</li>
<li>为什么这些公司被视为蓝筹股？</li>
<li>忘记无人驾驶出租车：电动飞行出租车是下一个重要投资</li>
<li>最活跃的股票：交易额与股票量</li>
<li>Crocs 股价在盈利超预期后下滑：它会反弹吗？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻警报由叙事科学技术和 MarketBeat 的财务数据生成，以向读者提供最快速和最准确的报道。本故事在发布前已经经 MarketBeat 的编辑团队审核。请将有关本故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><p>→ Recession-proof stocks? (From Stansberry Research)(Ad)</p>
<div class="lb-trans"><p>→ 衰退证明的股票？（来自 Stansberry Research）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MTY5" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9169&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in ASP Isotopes right now?</h2>
<div class="lb-trans"><h2>现在是否值得投资$1,000 购买 ASP 同位素？</h2>
</div><p>Before you consider ASP Isotopes, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 ASP 同位素之前，您可能想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASP Isotopes wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 追踪华尔街顶级和表现最佳的研究分析师以及他们每天向客户推荐的股票。MarketBeat 已确定了五支顶级分析师悄悄告诉客户现在购买的股票，然后才会被更广泛的市场注意到...而 ASP 同位素并不在这份名单上。</p>
</div><p>While ASP Isotopes currently has a &#34;Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管 ASP 同位素目前在分析师中有 “买入” 评级，但顶级分析师认为这五支股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五支股票</p>
</div>

ASP Isotopes Inc. (纳斯达克:ASPI) 空头头寸最新情况